Infant Study on Development of Celiac Enrolling

Infants under 6 months of age who have a first-degree relative with celiac are eligible to join the CDGEMM Study to understand the many factors that contribute to the development of celiac.

Research Roundup: Experimental Drug Eases Celiac Symptoms

Latiglutenase is an enzyme supplement that helps digest gluten. While clinical studies have not proven it prevents damage to the small intestine, it did relieve the participants’ most common complaints of abdominal pain, bloating, fatigue and constipation.

Study Sessions: Celiac research news roundup

Celiac hospitalization costs $7.4 million annually in the U.S., safe sourdough for celiac patients and more in this roundup of recent research news in the gluten-free community.

Advertisement

You can make a difference through celiac research

Learn three ways to campaign for the kind of celiac research that could lead to better quality of life, pharmaceutical treatments and alternative therapies.

Research Roundup: Celiac Disease Triggers

Read about the results of two recent studies into whether a common virus and cesarean section are celiac disease triggers.

Celiac Caregivers Face Emotional Burden

A recent study found family members who care for celiac patients face a significant emotional burden, with a greater risk for depression and anxiety.

Thyroid Disease in Celiac Patients

People with celiac disease have a higher risk for thyroid disease, according to recent research. Learn the signs to watch for and when to see a doctor.

New Infant Study on Celiac Disease Now Enrolling!

Infants under 6 months of age who have a first-degree relative with celiac disease are eligible to join the CDGEMM Study to understand the many factors that contribute to the development of celiac disease.